Schwab Announces Its Institutional Investor Day
WESTLAKE, Texas–(BUSINESS WIRE)–The Charles Schwab Corporation announced today that it has scheduled its Institutional Investor Day on Thursday, May... Read more.
DDC Enterprise Limited Reports Preliminary Unaudited Record High 2025 Revenue and Adjusted EBITDA (1); Expands Bitcoin Treasury to 2,183 BTC
NEW YORK–(BUSINESS WIRE)–DDC Enterprise Limited (the “Company,” “we,” or “DDC”) (NYSE American: DDC), today announced preliminary unaudited... Read more.
MarineMax Announces New Stock Repurchase Plan
OLDSMAR, Fla.–(BUSINESS WIRE)–MarineMax, Inc. (NYSE: HZO) (“MarineMax” or the “Company”), the world’s largest recreational boat and yacht retailer,... Read more.
Circadence Closes $16.4 Million Investment Round Amid Strong Revenue Growth and Launch of RangeGPT and Project Ares GEN3
BOULDER, Colo.–(BUSINESS WIRE)–Circadence today announced the successful close of a $16.4 million investment round led by Seneca Partners, reinforcing... Read more.
LPA Announces Reporting Dates for Full-Year 2025 Financial Results
SAN JOSE, Costa Rica–(BUSINESS WIRE)–Logistic Properties of the Americas (NYSE American: LPA) (“LPA” or the “Company”), a leading developer,... Read more.
Berkshire Hathaway Specialty Insurance Appoints Rory O’Broin as Global Head of Transactional Liability
BOSTON & LONDON–(BUSINESS WIRE)–Berkshire Hathaway Specialty Insurance (BHSI) today announced the appointment of Rory O’Broin as Global Head of... Read more.
Vasomune Therapeutics, Inc., and AnGes, Inc., Announce US FDA Clearance of Investigational New Drug (IND) Application For Pegevongitide (AV-001) Treatment in Resuscitation of Severely Burned Patients
TORONTO–(BUSINESS WIRE)–#ARDS–Vasomune Therapeutics, Inc., (“Vasomune”), a clinical-stage biopharmaceutical company, today announced... Read more.
Affinia Therapeutics Granted FDA Fast Track Designation for AFTX-201 as a Treatment for People Living with BAG3-Associated Dilated Cardiomyopathy (DCM)
An investigational medicine that addresses the genetic root cause of BAG3 DCM, AFTX-201 is being evaluated in the UPBEAT© clinical trial AFTX-201 is designed using... Read more.
NelsonHall Recognizes LTM as a Leader in GenAI & Process Automation for Banking
MUMBAI, India–(BUSINESS WIRE)–$LTM #AI—LTM, the Business Creativity partner to the world’s largest enterprises, has been recognized as a Leader... Read more.
NUBURU and Tekne Formalize Ukraine Industrial Deployment Platform Anchored by Operational GRAELION Units; Structured Framework Targets €80–120M Annual Program Scale
Existing In-Country Deployments, Military-Commercialized Configuration and Kyiv Joint Office Establish Execution Baseline DENVER–(BUSINESS WIRE)–$BURU... Read more.